Keogh, Geraldine F.

The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage

Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International

Hepatitis C virus researchDrug-Induced Hepatotoxicity and Protection

Cited by 379

Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-α, and C-reactive protein to a high-fat dietary load

Poppitt, S. D., Keogh, G. F., Lithander, F. E., Wang, Y., Mulvey, T. B., Chan, Y.-K., McArdle, B. H., & Cooper, G. J. S. (2008) · Nutrition

Adipokines, Inflammation, and Metabolic DiseasesFatty Acid Research and Health

Cited by 112

847 phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C

Gane, E. J., Orr, D. W., Weilert, F., Keogh, G. F., Gibson, M., Murphy, M. P., Smith, R. A., Lockhart, M. M., Frampton, C. M., & Taylor, K. M. (2008) · Journal of Hepatology

Hepatitis C virus researchCoenzyme Q10 studies and effects

Cited by 11